QUADRANT CAPITAL GROUP LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$6,0000.0%37
-17.8%
0.00%0.0%
Q2 2021$6,000
-33.3%
45
-30.8%
0.00%0.0%
Q1 2021$9,000
+200.0%
65
+150.0%
0.00%0.0%
Q4 2020$3,000
+200.0%
26
+100.0%
0.00%
Q3 2020$1,0000.0%13
+62.5%
0.00%
Q2 2020$1,00080.0%0.00%
Q1 2020$08
+166.7%
0.00%
Q4 2019$0
-100.0%
3
-99.7%
0.00%
-100.0%
Q1 2019$46,0001,0080.01%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 2,803,645$84,782,00078.57%
Cormorant Asset Management, LP 400,000$12,096,0002.49%
Deer VII & Co. Ltd. 175,075$5,294,0002.36%
QVT Financial LP 1,193,258$36,084,0001.86%
Foresite Capital Management I, LLC 55,767$1,686,0001.62%
Perceptive Advisors 445,000$13,457,0001.44%
SECTORAL ASSET MANAGEMENT INC 726,424$21,967,0000.92%
Iguana Healthcare Management, LLC 25,000$756,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 100,000$3,024,0000.37%
Eventide Asset Management 62,100$1,878,0000.26%
View complete list of ACCELERON PHARMA INC shareholders